Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    FAMP

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Synbias-Gemini Advances Fludarabine Phosphate for Europe
    Synbias-Gemini Advances Fludarabine Phosphate for Europe

    17 Dec 2025

    // PRESS RELEASE

    https://geminipharmchem.com/news/synbias-gemini-advances-fludarabine-phosphate-for-europe-from-shortage-to/

    PRESS RELEASE
    17 Dec 2025
    Share Share
    Four Gemini PharmChem APIs on EU Critical Medicines List
    Four Gemini PharmChem APIs on EU Critical Medicines List

    17 Nov 2025

    // PRESS RELEASE

    https://geminipharmchem.com/news/reinforcing-europes-oncology-supply-security/

    PRESS RELEASE
    17 Nov 2025
    Share Share
    Allogene advances FC lymphodepletion in ALPHA3 trial
    Allogene advances FC lymphodepletion in ALPHA3 trial

    01 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/01/3125763/0/en/Allogene-Therapeutics-Moves-Forward-with-Standard-Fludarabine-and-Cyclophosphamide-FC-Lymphodepletion-Regimen-in-the-ALPHA3-Trial-for-Cemacabtagene-Ansegedleucel-Cema-Cel-in-First-.html

    GLOBENEWSWIRE
    01 Aug 2025
    Share Share
    FDA updates label of 33-year-old cancer drug with dose & warning
    FDA updates label of 33-year-old cancer drug with dose & warning

    21 Nov 2024

    // ENDPTS

    https://endpts.com/fda-updates-label-of-33-year-old-cancer-drug-with-new-dose-and-warning/

    ENDPTS
    21 Nov 2024
    Share Share
    FDA Updates Label Of 33-Year-Old Cancer Drug With Warning
    FDA Updates Label Of 33-Year-Old Cancer Drug With Warning

    20 Nov 2024

    // ENDPTS

    https://endpts.com/fda-updates-label-of-33-year-old-cancer-drug-with-new-dose-and-warning/

    ENDPTS
    20 Nov 2024
    Share Share
    Nkarta's cell therapy needs specific pre-conditioning
    Nkarta's cell therapy needs specific pre-conditioning

    27 Jun 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/nkarta-touts-cell-therapy-effectiveness-specific-lymphodepletion-regiment-durability

    Max Bayer FIERCE BIOTECH
    27 Jun 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.